Acute febrile respiratory infection symptoms in Australian Hajjis at risk of exposure to Middle East respiratory syndrome coronavirus

Harunor Rashid, Osamah Barasheed and Robert Booy
Med J Aust 2013; 199 (7): . || doi: 10.5694/mja13.10984
Published online: 7 October 2013

To the Editor: Originating in Saudi Arabia in June 2012, the Middle East respiratory syndrome coronavirus (MERS-CoV), a virus similar to the severe acute respiratory syndrome (SARS) coronavirus, has reached nine countries and affected 130 people, of whom 58 (45%) have died.1 The threat of this epidemic to Australia is uncertain. During the SARS epidemic, Australia was the “lucky country” — it had just six probable SARS cases and no known fatalities.2 However, about 4500 pilgrims from Australia travel to Mecca, Saudi Arabia, for Hajj each year. About 50–150 people share a large tent (Box) and sleep in close proximity to each other for 5 days, which increases the risk of viral transmission.

  • Harunor Rashid1
  • Osamah Barasheed1
  • Robert Booy1,2

  • 1 National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Children’s Hospital at Westmead, Sydney, NSW.
  • 2 Sydney Emerging Infections and Biosecurity Institute, Sydney, NSW.

Competing interests:

Robert Booy has received funding from Baxter, CSL Limited, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche and Sanofi Pasteur for the conduct of sponsored research, travel to present at conferences and consultancy work. All this funding is directed to research accounts at the Children’s Hospital at Westmead.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.